Tocqueville Asset Management’s Puma Biotechnology PBYI Stock Holding History

Tocqueville Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108K	Buy	13,312 +352	+3%	+$2.58K	﹤0.01%	549
2026 Q1	$82.8K	Buy	+12,960	New	+$83.6K	﹤0.01%	541
2016 Q1	–	Sell	-2,650	Closed	-$208K	–	908
2015 Q4	$208K	Sell	2,650 -1,515	-36%	-$119K	﹤0.01%	844
2015 Q3	$314K	Hold	4,165	–	–	﹤0.01%	800
2015 Q2	$486K	Sell	4,165 -2,300	-36%	-$417K	0.01%	726
2015 Q1	$1.53M	Sell	6,465 -500	-7%	-$107K	0.02%	516
2014 Q4	$1.32M	Sell	6,965 -1,340	-16%	-$297K	0.01%	532
2014 Q3	$1.98M	Buy	8,305 +6,405	+337%	+$1.32M	0.02%	430
2014 Q2	$125K	Sell	1,900 -1,500	-44%	-$107K	﹤0.01%	1098
2014 Q1	$354K	Buy	3,400 +2,100	+162%	+$247K	﹤0.01%	656
2013 Q4	$135K	Buy	+1,300	New	+$76.3K	﹤0.01%	873

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tocqueville Asset Management's PBYI Position: Q2 2026 in Review

Tocqueville Asset Management increased its Puma Biotechnology (PBYI) stake by 2.7% in Q2 2026, buying an estimated $2.58K and bringing the position to 13,312 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Tocqueville Asset Management first reported a position in PBYI in Q4 2013 and has held it in 11 quarters since. The position peaked at $1.98M in Q3 2014. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Tocqueville Asset Management held 13,312 shares of Puma Biotechnology worth $108K as of Q2 2026.
Tocqueville Asset Management bought 352 Puma Biotechnology shares in Q2 2026, an estimated $2.58K.
Puma Biotechnology made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q2 2026, its #549 holding.
Tocqueville Asset Management first reported a position in Puma Biotechnology in Q4 2013 and has held it in 11 quarters since.
Tocqueville Asset Management's Puma Biotechnology position peaked at $1.98M in Q3 2014.
161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.